Medical dermatology.

We identified 118 patients and assessed patient demographics, associated conditions, comorbidities; number and size of the PG ulcers, anatomical location; subtype of PG, pathergy, histology, immunosuppressive therapy and prophylaxis used to prevent adverse effects of corticosteroid and immunosuppressive therapy B Results: b Of the 118 patients, 74 (63%) were female and 97% were Caucasian. Real-world disease characteristics and treatment patterns amongst patients with atopic dermat... Saxon D Smith SP 1 sp , Patrick Mahar SP 2 sp , David Truong (Non-Author Presenter) SP 3 sp , Can Mert SP 4 sp , John W Frew SP 5 sp SP I 1 i sp I Department of Dermatology, Sydney Adventist Hospital, Wahroonga, New South Wales, Australia,The Dermatology and Skin Cancer Centre, Gosford, Sydney, New South Wales, Australia, ANU Medical School, ANU College Health and Medicine, The Australian National University, Canberra, Australia i SP I 2 i sp I Eli Lilly and Company, West Ryde, Australia i SP I 3 i sp I Eli Lilly and Company, Australia i SP I 4 i sp I HaaPACS GmbH, Schriesheim, Germany i SP I 5 i sp I University of New South Wales, Ingham Institute of Applied Medical Research, Department of Dermatology Liverpool Hospital, Sydney, Australia i B Aims: b Atopic dermatitis (AD) is a complex, heterogenous disease that remains difficult to treat. Pyoderma Gangrenosum - A review of patient demographics, disease and treatment in 118 patient... Anthony Honigman SP 1 sp , Robert Kelly SP 2 sp SP I 1 i sp I Royal Melbourne Hospital, Melbourne, Australia i SP I 2 i sp I St Vincent's Hospital, Melbourne i B Aim: b To review and describe the epidemiology, presentation and management of patients diagnosed with pyoderma gangrenosum (PG) at St Vincent's hospital Melbourne (SVHM) Method: We reviewed patients with a diagnosis of PG treated at SVHM from January 20021 to November 2020. [Extracted from the article]